CONFERENCE COVERAGE
Psych Congress
Annual Meeting
2019 COVERAGE
- Lurasidone Linked to Relatively Low Risk for Metabolic Syndrome in Bipolar Depression
- Comorbidity Burden May Increase After Binge Eating Disorder Diagnosis
- Buprenorphine for Substance Use Disorder: Is Certification Right for Your Practice?
- Psychedelic-Assisted Therapy: How MDMA Is Changing Treatment for PTSD
- Novel Trace Amine Receptor Associated With Antipsychotic Effects in Schizophrenia
- Transdermal Asenapine: A Promising Potential Treatment Option for Adults With Schizophrenia
- Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome
- ALKS 3831 May Provide Long-Term Benefits for Acute Schizophrenia
- Growing Number of PAs Seeing, Treating Mental Health Disorders
- Dasotraline Improves Body Weight, Compulsive Behaviors in Binge Eating Disorder
- Discontinuing Esketamine Nasal Spray Not Linked to Withdrawal Syndrome
- Delayed-Release, Extended-Release Methylphenidate Improves Functional Impairment in Pediatric ADHD
Latest Tweets
Follow
@PsychCongress
Conference Coverage from
